Welcome to our dedicated page for Radnet SEC filings (Ticker: RDNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The RadNet, Inc. (RDNT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a NASDAQ-listed issuer. RadNet files reports and current updates with the U.S. Securities and Exchange Commission in connection with its operations as a national provider of freestanding, fixed-site diagnostic imaging services and as the parent of the DeepHealth digital health division.
Among the filings that investors commonly review are annual reports on Form 10-K and quarterly reports on Form 10-Q, which present information on RadNet’s Imaging Center and Digital Health reportable segments, revenue composition, imaging volumes, liquidity and capital structure. Current reports on Form 8-K are used to disclose specific material events, such as the release of quarterly financial results or the filing of a prospectus supplement under an automatic shelf registration statement. For example, RadNet has filed 8-Ks to furnish press releases detailing financial results for quarters ended June 30, 2025 and September 30, 2025, and to report the filing of a prospectus supplement registering shares of common stock for resale by selling stockholders.
Through this filings page, users can also monitor documents related to securities offerings, including prospectus supplements and associated legal opinions, as well as other disclosures that may affect the company’s capital markets activity. Forms related to insider transactions, such as Form 4, and proxy materials on executive compensation and governance are part of the broader SEC record and can be relevant for understanding management incentives and ownership changes.
Stock Titan enhances access to these filings by pairing real-time updates from the SEC’s EDGAR system with AI-powered summaries that explain key points in plain language. This can help readers interpret lengthy documents such as 10-K and 10-Q reports, understand the implications of 8-K announcements and quickly identify notable items in RadNet’s regulatory history. For anyone analyzing RDNT, the SEC filings page is a central source for official, time-stamped information on the company’s financial condition, segment performance and capital markets activity.
RadNet EVP and Chief Science Officer Alma Gregory Sorensen reported a charitable donation of 5,600 shares of common stock on June 17, 2025. The transaction was executed at $0 as it was a gift (Transaction Code: G).
Following the transaction, Sorensen maintains direct beneficial ownership of 1,165,345 shares of RadNet common stock. The filing indicates that Sorensen serves in dual roles as both a Director and Executive Officer (EVP, Chief Science Officer) of the company.
Key Transaction Details:
- Transaction Type: Charitable Donation
- Direct Ownership Maintained
- No derivative securities were involved in this transaction
- Filing was signed by Jose Gamez as Attorney-in-Fact on June 18, 2025